Back to Search
MARY LOUDER, DO
DO
Family Medicine Physician
NPI: 1437220241Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
TL-1033(SC)CO 40167(CO)34-008880(OH)MI5101012165(MI)02003339A(IN)
Research & Publications (18)
Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.
PMID 19264769·J Virol·2009
8-other
Solution concentration influences voluntary consumption of nicotine under multiple bottle conditions.
PMID 19100280·Pharmacol Biochem Behav·2009
7-preclinical
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.
PMID 19004942·J Virol·2009
8-other
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
PMID 18824060·Vaccine·2008
3-trial
Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
PMID 17721546·Nat Med·2007
8-other
Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.
PMID 17093191·J Virol·2007
8-other
HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.
PMID 16005039·Virology·2005
8-other
Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.
PMID 15994779·J Virol·2005
8-other
Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.
PMID 15837367·Vaccine·2005
8-other
Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
PMID 15613305·J Virol·2005
7-preclinical
Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.
PMID 15582651·Virology·2005
7-preclinical
The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.
PMID 14963135·J Virol·2004
8-other
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
PMID 14685242·Nature·2003
8-other
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells.
PMID 12402193·J Infect Dis·2002
8-other
Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.
PMID 11967298·J Virol·2002
4-observational
Human dendritic cells as targets of dengue virus infection.
PMID 11924831·J Investig Dermatol Symp Proc·2001
8-other
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.
PMID 11112486·Virology·2000
8-other
Human skin Langerhans cells are targets of dengue virus infection.
PMID 10888933·Nat Med·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2695 PINEHILL DR
HOLLAND, MI 49424 - Phone
- (616) 201-8955
Quick Facts
- NPI
- 1437220241
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 5
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile